Other equities analysts also recently issued research reports about the stock. ValuEngine upgraded shares of Veru from a “sell” rating to a “hold” rating in a research note on Friday, November 1st. HC Wainwright restated a “buy” rating and issued a $6.00 price target (up previously from $4.50) on shares of Veru in a research note on Tuesday. Finally, Zacks Investment Research upgraded shares of Veru from a “hold” rating to a “buy” rating and set a $3.00 price target for the company in a research note on Thursday, December 19th. One research analyst has rated the stock with a hold rating and eight have given a buy rating to the company. Veru currently has an average rating of “Buy” and a consensus price target of $6.14.
NASDAQ:VERU opened at $3.74 on Friday. The company has a fifty day simple moving average of $3.32 and a two-hundred day simple moving average of $2.37. The company has a market cap of $243.25 million, a price-to-earnings ratio of -20.78 and a beta of 0.53. The company has a quick ratio of 0.94, a current ratio of 1.20 and a debt-to-equity ratio of 0.09. Veru has a 52 week low of $1.18 and a 52 week high of $4.74.
In related news, CEO Mitchell Shuster Steiner sold 25,000 shares of the business’s stock in a transaction on Thursday, November 7th. The shares were sold at an average price of $2.01, for a total transaction of $50,250.00. Insiders own 29.50% of the company’s stock.
Hedge funds have recently modified their holdings of the stock. Squarepoint Ops LLC acquired a new position in shares of Veru during the third quarter worth $39,000. BlackRock Inc. grew its stake in shares of Veru by 65.4% during the second quarter. BlackRock Inc. now owns 228,934 shares of the company’s stock worth $487,000 after purchasing an additional 90,530 shares in the last quarter. Alpine Global Management LLC acquired a new position in shares of Veru during the fourth quarter worth $80,000. Wedge Capital Management L L P NC grew its stake in shares of Veru by 59.2% during the fourth quarter. Wedge Capital Management L L P NC now owns 294,207 shares of the company’s stock worth $986,000 after purchasing an additional 109,370 shares in the last quarter. Finally, Renaissance Technologies LLC grew its stake in shares of Veru by 183.1% during the second quarter. Renaissance Technologies LLC now owns 262,160 shares of the company’s stock worth $558,000 after purchasing an additional 169,550 shares in the last quarter. Hedge funds and other institutional investors own 9.93% of the company’s stock.
Veru Inc operates as an oncology and urology biopharmaceutical company. The company operates through two segments, Commercial, and Research and Development. It offers FC2 Female Condom for unintended pregnancy and sexually transmitted infections, including HIV/AIDS and the Zika virus; and PREBOOST benzocaine medicated individual wipes for the prevention of premature ejaculation.
Featured Article: What is a back-end load?
Receive News & Ratings for Veru Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veru and related companies with MarketBeat.com's FREE daily email newsletter.